Oren Hershkovitz

Amministratore Delegato presso ENLIVEX THERAPEUTICS LTD.

Patrimonio netto: 34 673 $ in data 31/05/2024

47 anni

Health Technology

Consumer Services

Posizioni attive di Oren Hershkovitz

Società	Posizione	Inizio	Fine
ENLIVEX THERAPEUTICS LTD.	Amministratore Delegato	16/11/2019	-
OPKO Biologics Ltd. OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.	Direttore/Membro del Consiglio	01/09/2016	-

Ben-Gurion University of the Negev

Doctorate Degree

Distribuzione geografica

Israele

Posizioni

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ENLIVEX THERAPEUTICS LTD.	Health Technology

Aziende private	1
OPKO Biologics Ltd. OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.	Health Technology

Aziende private

Health Technology